Two ways to reduce pain during a baby's eye exam
Part of Eyes & vision, Genetic & congenital, Pain, Women’s health & pregnancy clinical trials.
This study tests two drug-free methods to help reduce pain when premature babies get a special eye exam for retinopathy of prematurity. It may help your baby feel more comfortable during the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born before 34 weeks of pregnancy.
- Your baby's birth weight was 5.5 pounds (2500 grams) or less.
- Your baby had no painful procedures in the hour before the eye exam.
- Your baby was fed at least one hour before the exam.
- You have given permission for your baby to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether fentanyl (a pain medicine given as a nasal spray) can help preterm babies feel less pain during a routine eye exam for retinopathy of prematurity. It is designed for babies who are stable and need this exam as part of their NICU care.
This study tests a new eye imaging device to check for retinopathy of prematurity (ROP), a condition that can affect vision in premature babies. It may help doctors diagnose ROP earlier and more easily at the bedside.
This study looks at the tiny blood vessels in the back of the eye (retina) of premature infants who are at risk for retinopathy of prematurity, a condition that can harm vision. It aims to improve care and monitoring by using advanced eye imaging to see more detail than current methods.
This study looks at long-term eye health in people who were born prematurely and had retinopathy of prematurity (ROP) screening as babies. It aims to understand how the eyes develop over many years.
This trial tests an educational program for parents to help them understand why their premature baby needs eye screening for retinopathy of prematurity (a condition that can affect vision). It may help parents feel more confident and informed about the screening process.
This trial tests whether a low dose of conbercept, given as an eye injection, can safely treat type 1 ROP (an eye disease in premature babies). The goal is to stop abnormal blood vessel growth and prevent vision loss.
Hear when a new Retinopathy of Prematurity (ROP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.